Mani 3

This statement has been prepared in response to the decision of the Australian Government Therapeutic Goods Administration (TGA) to withdraw pholcodine-containing products from the market. Evidence shows that pholcodine consumption in the 12-month period prior to a general an...

PG31(A)BP Guideline on checking anaesthesia delivery systems Background Paper

CPD ER Major Haemorrhage recognition of suitability form 2023